Record ID | marc_loc_updates/v39.i26.records.utf8:6394094:4741 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_updates/v39.i26.records.utf8:6394094:4741?format=raw |
LEADER: 04741cam a2200505 a 4500
001 2009939644
003 DLC
005 20110625101747.0
008 091020s2010 njua b 001 0 eng
010 $a 2009939644
015 $aGBA987184$2bnb
016 7 $a015362133$2Uk
020 $a9781607610571 (hbk.)
020 $a1607610574 (hbk.)
020 $a1607610582 (ebk.)
020 $a9781607610588 (ebk.)
035 $a(OCoLC)ocn503630811
040 $aUKM$cUKM$dFUH$dCUS$dCOU$dYDXCP$dDLC
042 $aukblcatcopy$alccopycat
050 00 $aRM301.25$b.M68 2010
060 4 $aQV 744 M932 2010
082 04 $a615.580724$222
245 00 $aMouse models for drug discovery :$bmethods and protocols /$cedited by Gabriele Proetzel and Michael V. Wiles.
260 $aTotowa, N.J. :$bHumana,$cc2010.
300 $axii, 421 p. :$bill. (some col.) ;$c26 cm.
490 1 $aMethods in molecular biology,$x1064-3745 ;$v602
490 1 $aSpringer protocols
504 $aIncludes bibliographical references and index.
505 0 $aImproving toxicity screening and drug development by using genetically defined strains / Michael F.W. Festing -- Sophisticated mouse: protecting a precious reagent / Michael V. Wiles, Rob A. Taft -- Genetically engineered mouse models in drug discovery research / Rosalba Sacca, Sandra J. Engle, Wenning Qin, Jeffrey L. Stock, John D. McNeish -- Engineering the mouse genome to model human disease for drug discovery / Frank Koentgen, Gabriele Suess, Dieter Naf -- Profiling of drug action using reporter mice and molecular imaging / Gianpaolo Rando, Andrea Biserni, Paolo Ciana, Adriana Maggi -- Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies / Derry C. Roopenian, Gregory J. Christianson, Thomas J. Sproule -- Development of novel major histocompatibility complex class I and class II-defecient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease / Steve Pino, Michael A. Brehm, Laurence Covassin-Barberis, Marie King, Bruce Gott, Thomas H. Chase, Jennifer Wagner, Lisa Burzenski, Oded Foreman, Dale L. Greiner, Leonard D. Shultz -- Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type I diabetes in humans / David V. Serreze, Marijke Niens, John Kulik, Teresa P. DeLorenzo -- Mouse models of type II diabetes mellitus in drug discovery / Helene Baribault -- Cholesterol absorption and metabolism / Philip N. Howles -- Collegen-induced arthritis in mice / Lisette Bevaart, Margriet J. Vervoordeldonk, Paul P. Tak -- Skin diseases in laboratory mice: approaches to drug tartget identification and efficacy screening / John P. Sundbert, Kathleen A. Sliva, Caroline McPhee, Lloyd E. King -- Models of metastasis in drug discovery / James E. Talmadge -- Methods for evaluating effects of an ironotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging / David Surguladze, Philipp Steiner, Marie Prewetz, James R. Tonra -- CML mouse model in translational research / Cong Peng, Shaoguang Li -- Mouse models for studying depression-like states and antidepressant drugs / Carisa L. Bergner, Amanda N. Smolinsky, Peter C. Hart, Brett D. Dufour, Rupert J. Egan, Justin L. LaPorte, Allan V. Kaleuff -- Virus-delivered RNA interference in mouse brain to study addiction-related behaviors / Amy W. Lasek, Nourredine Azouaou -- Experimental models of anxiety for drug discovery and brain research / Peter C. Hart, Carisa L. Bergner, Amanda N. Smolinsky, Brett D. Dufour, Rupert J. Egan, Justin L. LaPorte, Allan v. Kalueff -- Mouse models of neurodegenerative diseases: criteria and general methodology / Christopher Janus, Hans Welzl -- Neuromuscular disease models and analysis / Robert W. Burgess, Gregory A. Cox, Kevin L. Seburn -- Murine model of cutaneous infection with Streptococcus pyogenes / Eva Medina -- Murine model of pneumococcal pneumonia / Eva Medina -- Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP) / Eva Medina.
650 0 $aAnimal models in research.
650 0 $aDrug development.
650 0 $aDrugs$xPhysiological effect.
650 0 $aMice$xEffect of drugs on.
650 0 $aMice$xDiseases$xMolecular aspects.
650 2 $aDrug Design.
650 2 $aDrug Evaluation, Preclinical.
650 2 $aDrug Discovery.
650 2 $aModels, Animal.
650 2 $aDisease Models, Animal.
650 2 $aMice.
650 2 $aMice, Transgenic.
700 1 $aProetzel, Gabriele.
700 1 $aWiles, Michael V.
830 0 $aMethods in molecular biology (Clifton, N.J.) ;$vv. 602.
830 0 $aSpringer protocols.